http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/ News About Tech, Money and Innovation Wed, 25 Nov 2009 09:59:47 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/comment-page-1/#comment-596542 VentureBeat » Life sciences briefing: Friday, Oct. 26, 2007 Fri, 26 Oct 2007 18:15:26 +0000 http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/#comment-596542 [...] shares at $11 apiece, well under the $12 to $14 range it previously established. (Our coverage is here.) Power Medical could sell as many as 4.4 million shares in the [...] [...] shares at $11 apiece, well under the $12 to $14 range it previously established. (Our coverage is here.) Power Medical could sell as many as 4.4 million shares in the [...]

]]> http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/comment-page-1/#comment-582514 VentureBeat » Life sciences briefing: Tuesday, Oct. 16, 2007 Wed, 17 Oct 2007 13:11:59 +0000 http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/#comment-582514 [...] candidate is likely to have bad side effects down th road. Our earlier coverage of the company is here and [...] [...] candidate is likely to have bad side effects down th road. Our earlier coverage of the company is here and [...]

]]> http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/comment-page-1/#comment-576158 VentureBeat » Bellicum’s prostate-cancer vaccine: Dendritic cells served with a genetic twist Fri, 12 Oct 2007 22:17:57 +0000 http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/#comment-576158 [...] genetic twist on the basic notion of a cancer vaccine. (See our previous coverage in the sixth item here.) Like Dendreon, Bellicum’s basic strategy relies on dendritic cells, which are workhorses of [...] [...] genetic twist on the basic notion of a cancer vaccine. (See our previous coverage in the sixth item here.) Like Dendreon, Bellicum’s basic strategy relies on dendritic cells, which are workhorses of [...]

]]> http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/comment-page-1/#comment-572392 VentureBeat » New Leaf raises $450M life-sciences fund Wed, 10 Oct 2007 17:58:49 +0000 http://venturebeat.com/2007/10/10/life-sciences-briefing-wednesday-oct-10-2007/#comment-572392 [...] our story about this bicoastal VC firm in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story about this bicoastal VC firm in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>